Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ATM serine/threonine kinase | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.0841 | 0.0803 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.2124 | 0.2124 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0022 | 0.0041 | 0.0041 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0217 | 0.0217 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0026 | 0.017 | 0.0385 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0747 | 0.0747 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.2293 | 0.2261 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.003 | 0.0308 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.1688 | 0.1688 |
Entamoeba histolytica | hypothetical protein | 0.003 | 0.0308 | 1 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0217 | 0.0217 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0022 | 0.0041 | 0.0041 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.003 | 0.0308 | 0.0308 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0022 | 0.0041 | 0.0041 |
Brugia malayi | PHD-finger family protein | 0.003 | 0.0311 | 0.0271 |
Giardia lamblia | GTOR | 0.0022 | 0.0041 | 0.5 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0125 | 0.3407 | 0.5 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0125 | 0.3407 | 1 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0021 | 0.0024 | 0.0024 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.1688 | 0.1688 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0025 | 0.0142 | 0.0142 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0125 | 0.3407 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0844 | 0.0844 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0937 | 0.0937 |
Echinococcus multilocularis | zinc finger protein | 0.0024 | 0.01 | 0.01 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0747 | 0.0747 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.003 | 0.0308 | 0.0794 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0022 | 0.0041 | 0.0041 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0022 | 0.0041 | 0.0041 |
Leishmania major | phosphatidylinositol kinase related protein, putative | 0.0022 | 0.0042 | 0.0004 |
Echinococcus granulosus | serine protein kinase ATM | 0.003 | 0.0308 | 0.0308 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.1829 | 0.1829 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0125 | 0.3407 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0024 | 0.01 | 0.01 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0125 | 0.3407 | 0.5 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0022 | 0.0042 | 0.0004 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.003 | 0.0308 | 0.0794 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.003 | 0.0308 | 0.0268 |
Toxoplasma gondii | FATC domain-containing protein | 0.003 | 0.0308 | 0.0794 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.1013 | 0.1013 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0142 | 0.0142 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0022 | 0.0041 | 0.0041 |
Echinococcus granulosus | zinc finger protein | 0.0024 | 0.01 | 0.01 |
Echinococcus multilocularis | serine protein kinase ATM | 0.003 | 0.0308 | 0.0308 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0125 | 0.3407 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0022 | 0.0041 | 0.0041 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.017 | 0.017 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0022 | 0.0041 | 0.0041 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0217 | 0.0217 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.7079 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | = 2.8184 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) [Related pubchem assays: 1379 ] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.